A Fusion Protein between Streptavidin and the Endogenous TLR4 Ligand EDA Targets Biotinylated Antigens to Dendritic Cells and Induces T Cell ResponsesIn Vivo

Selection of an Antibody Library Identifies a Pathway to Induce Immunity by Targeting CD36 on Steady-State CD8 + Dendritic Cells

(2014) E. Tagliani et al.   JOURNAL OF IMMUNOLOGY

Circulating specific antibodies enhance systemic cross-priming by delivery of complexed antigen to dendritic cells in vivo

(2012) Nadine van Montfoort et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Adjuvant Combination and Antigen Targeting as a Strategy to Induce Polyfunctional and High-Avidity T-Cell Responses against Poorly Immunogenic Tumors

(2011) F. Aranda et al.   CANCER RESEARCH

Eradication of large tumors expressing human papillomavirus E7 protein by therapeutic vaccination with E7 fused to the extra domain a from fibronectin

(2011) Cristina Mansilla et al.   INTERNATIONAL JOURNAL OF CANCER

Dendritic cell-targeted protein vaccines: a novel approach to induce T-cell immunity

(2011) C. Trumpfheller et al.   JOURNAL OF INTERNAL MEDICINE

Tumor cells engineered to codisplay on their surface 4-1BBL and LIGHT costimulatory proteins as a novel vaccine approach for cancer immunotherapy

(2010) R K Sharma et al.   CANCER GENE THERAPY

The immunogenicity of CpG-antigen conjugates

(2009) Hermann Wagner   ADVANCED DRUG DELIVERY REVIEWS

Immunization against hepatitis C virus with a fusion protein containing the extra domain A from fibronectin and the hepatitis C virus NS3 protein

(2009) Cristina Mansilla et al.   JOURNAL OF HEPATOLOGY

Plasmacytoid dendritic cells efficiently cross-prime naive T cells in vivo after TLR activation

(2008) J. Mouries et al.   BLOOD

Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin

(2008) David Sancho et al.   JOURNAL OF CLINICAL INVESTIGATION